AMD |
Age-related macular degeneration |
Anti-VEGF |
Drugs that inhibit vascular endothelial growth factor |
BRVO |
Branch retinal vein occlusion |
CRVO |
Central retinal vein occlusion |
DARPins |
Designed ankyrin repeat proteins |
DME |
diabetic macular edema |
DR |
Diabetic retinopathy |
EG-VEGF |
Endocrine gland-derived vascular endothelial growth factor |
IOI |
Intraocular inflammation |
IOP |
Intraocular pressure |
ME |
Macular edema |
NP-1 |
Neuropilin-1 |
NP-2 |
Neurophilin-2 |
NPDR |
Non-proliferative diabetic retinopathy |
PCV |
Polypoidal choroidal vasculopathy |
PDR |
Proliferative diabetic retinopathy |
PDT |
Photodynamic therapy |
PlGF |
Placental growth factor |
POHS |
Presumed ocular histoplasmosis syndrome |
PRP |
Panretinal laser photocoagulation |
RPE |
Retinal pigment epithelium |
RVO |
Retinal vein occlusion |
VEGF |
Vascular endothelial growth factor |
VEGFR |
Vascular endothelial growth factor receptor |